Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College, 152-160 Pearse Street, Dublin 2, Ireland.
Toxicol Appl Pharmacol. 2014 Feb 1;274(3):425-35. doi: 10.1016/j.taap.2013.12.011. Epub 2013 Dec 22.
Reports from human case studies indicate a half-life for inorganic mercury in the brain in the order of years-contradicting older radioisotope studies that estimated half-lives in the order of weeks to months in duration. This study systematically reviews available evidence on the retention time of inorganic mercury in humans and primates to better understand this conflicting evidence. A broad search strategy was used to capture 16,539 abstracts on the Pubmed database. Abstracts were screened to include only study types containing relevant information. 131 studies of interest were identified. Only 1 primate study made a numeric estimate for the half-life of inorganic mercury (227-540 days). Eighteen human mercury poisoning cases were followed up long term including autopsy. Brain inorganic mercury concentrations at death were consistent with a half-life of several years or longer. 5 radionucleotide studies were found, one of which estimated head half-life (21 days). This estimate has sometimes been misinterpreted to be equivalent to brain half-life-which ignores several confounding factors including limited radioactive half-life and radioactive decay from surrounding tissues including circulating blood. No autopsy cohort study estimated a half-life for inorganic mercury, although some noted bioaccumulation of brain mercury with age. Modelling studies provided some extreme estimates (69 days vs 22 years). Estimates from modelling studies appear sensitive to model assumptions, however predications based on a long half-life (27.4 years) are consistent with autopsy findings. In summary, shorter estimates of half-life are not supported by evidence from animal studies, human case studies, or modelling studies based on appropriate assumptions. Evidence from such studies point to a half-life of inorganic mercury in human brains of several years to several decades. This finding carries important implications for pharmcokinetic modelling of mercury and potentially for the regulatory toxicology of mercury.
来自人体病例研究的报告表明,无机汞在大脑中的半衰期为数年-与旧的放射性同位素研究相矛盾,后者估计半衰期为数周到数月。本研究系统地回顾了关于无机汞在人类和灵长类动物中滞留时间的现有证据,以更好地理解这一相互矛盾的证据。采用广泛的搜索策略在 Pubmed 数据库中捕获了 16539 个摘要。对摘要进行筛选,只包括包含相关信息的研究类型。确定了 131 项感兴趣的研究。只有一项灵长类动物研究对无机汞的半衰期进行了数值估计(227-540 天)。18 例人类汞中毒病例进行了长期随访,包括尸检。死亡时大脑中的无机汞浓度与数年或更长时间的半衰期一致。发现了 5 项放射性核素研究,其中一项估计了头部半衰期(21 天)。这一估计有时被误解为相当于脑半衰期-这忽略了几个混杂因素,包括有限的放射性半衰期和来自周围组织(包括循环血液)的放射性衰减。虽然有些研究注意到大脑汞随年龄的生物积累,但没有尸检队列研究估计无机汞的半衰期。建模研究提供了一些极端估计值(69 天与 22 年)。然而,建模研究的预测似乎对模型假设敏感,但是基于长半衰期(27.4 年)的预测与尸检结果一致。总之,动物研究、人体病例研究或基于适当假设的建模研究都没有支持半衰期较短的证据。这些研究的证据表明,人类大脑中的无机汞半衰期为数年到数十年。这一发现对汞的药代动力学建模以及潜在的汞的监管毒理学具有重要意义。